Richard Reynolds Selected Research

Richard Reynolds Research Topics

Disease

37	Multiple Sclerosis 07/2022 - 09/2002
21	Inflammation (Inflammations) 07/2022 - 02/2006
17	Demyelinating Diseases (Demyelinating Disease) 07/2022 - 07/2002
6	Disease Progression 10/2022 - 09/2002
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 07/2012 - 07/2002
4	Necrosis 11/2022 - 12/2013
3	Neuroinflammatory Diseases 10/2021 - 07/2008
3	Parkinson Disease (Parkinson's Disease) 10/2021 - 08/2012
3	Cognitive Dysfunction 01/2021 - 09/2014
3	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2015 - 04/2006
2	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 08/2012
2	Atrophy 01/2021 - 01/2016
2	Chronic Progressive Multiple Sclerosis 01/2016 - 12/2013
2	Gliosis 07/2012 - 06/2012
1	Neurobehavioral Manifestations 01/2022
1	Stroke (Strokes) 08/2019
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 07/2019
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 07/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Seizures (Absence Seizure) 01/2016
1	Central Nervous System Diseases (CNS Diseases) 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2013
1	Rheumatoid Arthritis 03/2012
1	Human Influenza (Influenza) 01/2012
1	Epstein-Barr Virus Infections 07/2010
1	Relapsing-Remitting Multiple Sclerosis 02/2010

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2006
9	CytokinesIBA 01/2021 - 12/2008
7	Myelin-Oligodendrocyte GlycoproteinIBA 07/2022 - 07/2002
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2015
5	RNA (Ribonucleic Acid)IBA 12/2019 - 01/2010
4	Complement System Proteins (Complement)IBA 01/2022 - 01/2016
4	Mitochondrial DNA (mtDNA)IBA 08/2021 - 03/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 12/2008
3	Type I Tumor Necrosis Factor ReceptorsIBA 10/2022 - 12/2019
3	Glutamic Acid (Glutamate)FDA Link 12/2020 - 02/2010
3	Connexin 43 (Connexin43)IBA 09/2014 - 06/2012
3	AntibodiesIBA 06/2014 - 07/2002
3	Messenger RNA (mRNA)IBA 12/2013 - 01/2010
2	ParvalbuminsIBA 10/2022 - 01/2021
2	Lymphotoxin-alpha (Lymphotoxin)IBA 07/2022 - 12/2020
2	Neurotransmitter Agents (Neurotransmitter)IBA 10/2021 - 01/2018
2	ProteomeIBA 01/2021 - 01/2020
2	InterferonsIBA 12/2020 - 12/2020
2	HLA-DR15 antigenIBA 11/2020 - 01/2018
2	IronIBA 11/2019 - 07/2015
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 01/2008
2	ChemokinesIBA 01/2016 - 07/2008
2	PK 11195 (PK11195)IBA 01/2015 - 05/2014
2	incomplete Freund's adjuvantIBA 12/2013 - 07/2013
2	Pharmaceutical PreparationsIBA 03/2012 - 05/2009
2	polysialyl neural cell adhesion moleculeIBA 03/2007 - 09/2002
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2022
1	Phosphotransferases (Kinase)IBA 11/2022
1	PrebioticsIBA 10/2021
1	SynucleinsIBA 10/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021
1	Carisoprodol (Soma)FDA LinkGeneric 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2020
1	N-Methylaspartate (NMDA)IBA 12/2020
1	InterleukinsIBA 05/2020
1	Interleukin-9 (Interleukin 9)IBA 05/2020
1	Type II Tumor Necrosis Factor ReceptorsIBA 12/2019
1	Cytidine Triphosphate (CTP)IBA 08/2019
1	NeuropeptidesIBA 01/2018
1	Cholinergic Agents (Cholinergics)IBA 01/2018
1	GalaninIBA 01/2018
1	lactacystinIBA 01/2018
1	Interleukin-2 (IL2)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Oligoclonal BandsIBA 01/2017
1	Natalizumab (Tysabri)FDA Link 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	ParaffinIBA 01/2016
1	gamma-Aminobutyric Acid (GABA)IBA 01/2016
1	Formaldehyde (Formol)FDA Link 01/2016
1	Potassium Channels (Potassium Channel)IBA 06/2014
1	Interferon-gamma (Interferon, gamma)IBA 12/2013
1	Alemtuzumab (Campath)FDA Link 09/2013
1	Interleukin-17 (Interleukin 17)IBA 09/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2013
1	Glycoproteins (Glycoprotein)IBA 07/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2013
1	CalreticulinIBA 07/2013
1	PolymersIBA 07/2013
1	EnzymesIBA 03/2012
1	dimethylethylsilylimidazoleIBA 03/2012
1	Natural Cytotoxicity Triggering Receptor 1IBA 01/2012
1	LigandsIBA 01/2012
1	Biological ProductsIBA 01/2012
1	Indicators and Reagents (Reagents)IBA 10/2010
1	B-Cell Activating FactorIBA 07/2010
1	Sphingosine-1-Phosphate ReceptorsIBA 02/2010

Therapy/Procedure

3	Therapeutics 01/2018 - 02/2006
1	Injections 07/2022
1	Transplantation 10/2021
1	Diet Therapy (Therapy, Diet) 10/2021
1	Immunotherapy 09/2013
1	Stem Cell Transplantation 09/2013
1	Intradermal Injections 07/2013